Literature DB >> 23772033

Trp53 deficiency protects against acute intestinal inflammation.

Martina E Spehlmann1, Carolin F Manthey, Sara M Dann, Elaine Hanson, Sukhman S Sandhu, Linus Y Liu, Farid K Abdelmalak, Michaela A Diamanti, Kristin Retzlaff, Jürgen Scheller, Stefan Rose-John, Florian R Greten, Jean Y J Wang, Lars Eckmann.   

Abstract

The p53 protein has not only important tumor suppressor activity but also additional immunological and other functions, whose nature and extent are just beginning to be recognized. In this article, we show that p53 has a novel inflammation-promoting action in the intestinal tract, because loss of p53 or the upstream activating kinase, ATM, protects against acute intestinal inflammation in murine models. Mechanistically, deficiency in p53 leads to increased survival of epithelial cells and lamina propria macrophages, higher IL-6 expression owing to enhanced glucose-dependent NF-κB activation, and increased mucosal STAT3 activation. Blockade or loss of IL-6 signaling reverses the protective effects of p53 deficiency. Conversely, IL-6 treatment protects against acute colitis in a manner dependent on STAT3 signaling and induction of cytoprotective factors in epithelial cells. Together, these results indicate that p53 promotes inflammation in the intestinal tract through suppression of epithelium-protective factors, thus significantly expanding the spectrum of physiological and immunological p53 activities unrelated to cancer formation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23772033      PMCID: PMC3710108          DOI: 10.4049/jimmunol.1201716

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  59 in total

Review 1.  Nuclear factor-kappaB activation: a question of life or death.

Authors:  Shishir Shishodia; Bharat B Aggarwal
Journal:  J Biochem Mol Biol       Date:  2002-01-31

Review 2.  Radical induction theory of ulcerative colitis.

Authors:  Jay Pravda
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

3.  Activated p53 induces NF-kappaB DNA binding but suppresses its transcriptional activation.

Authors:  Keiko Kawauchi; Keigo Araki; Kei Tobiume; Nobuyuki Tanaka
Journal:  Biochem Biophys Res Commun       Date:  2008-05-12       Impact factor: 3.575

Review 4.  Anti-interleukin-6 receptor antibody treatment in inflammatory autoimmune diseases.

Authors:  Changhai Ding; Graeme Jones
Journal:  Rev Recent Clin Trials       Date:  2006-09

5.  Regulation of arthritis by p53: critical role of adaptive immunity.

Authors:  Egle Simelyte; Sanna Rosengren; David L Boyle; Maripat Corr; Douglas R Green; Gary S Firestein
Journal:  Arthritis Rheum       Date:  2005-06

6.  Phosphorylation of p53 at serine 15 in A549 pulmonary epithelial cells exposed to vanadate: involvement of ATM pathway.

Authors:  Katsura Suzuki; Kiyoshi Inageda; Gen Nishitai; Masato Matsuoka
Journal:  Toxicol Appl Pharmacol       Date:  2007-01-08       Impact factor: 4.219

7.  IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens.

Authors:  Sara M Dann; Martina E Spehlmann; Dustin C Hammond; Mitsutoshi Iimura; Koji Hase; Lillian J Choi; Elaine Hanson; Lars Eckmann
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

8.  Opposing functions of IKKbeta during acute and chronic intestinal inflammation.

Authors:  Lars Eckmann; Tim Nebelsiek; Alexander A Fingerle; Sara M Dann; Jörg Mages; Roland Lang; Sylvie Robine; Martin F Kagnoff; Roland M Schmid; Michael Karin; Melek C Arkan; Florian R Greten
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-24       Impact factor: 11.205

9.  Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease.

Authors:  Lauren A Zenewicz; George D Yancopoulos; David M Valenzuela; Andrew J Murphy; Sean Stevens; Richard A Flavell
Journal:  Immunity       Date:  2008-12-19       Impact factor: 31.745

10.  Genetic evidence for a protective role for heat shock factor 1 and heat shock protein 70 against colitis.

Authors:  Ken-Ichiro Tanaka; Takushi Namba; Yasuhiro Arai; Mitsuaki Fujimoto; Hiroaki Adachi; Gen Sobue; Koji Takeuchi; Akira Nakai; Tohru Mizushima
Journal:  J Biol Chem       Date:  2007-06-07       Impact factor: 5.157

View more
  20 in total

Review 1.  IL-6 biology: implications for clinical targeting in rheumatic disease.

Authors:  Leonard H Calabrese; Stefan Rose-John
Journal:  Nat Rev Rheumatol       Date:  2014-08-19       Impact factor: 20.543

Review 2.  IL-6 as a keystone cytokine in health and disease.

Authors:  Christopher A Hunter; Simon A Jones
Journal:  Nat Immunol       Date:  2015-05       Impact factor: 25.606

3.  Deficiency in the anti-apoptotic protein DJ-1 promotes intestinal epithelial cell apoptosis and aggravates inflammatory bowel disease via p53.

Authors:  Jie Zhang; Min Xu; Weihua Zhou; Dejian Li; Hong Zhang; Yi Chen; Longgui Ning; Yuwei Zhang; Sha Li; Mengli Yu; Yishu Chen; Hang Zeng; Li Cen; Tianyu Zhou; Xinxin Zhou; Chao Lu; Chaohui Yu; Youming Li; Jing Sun; Xiaoni Kong; Zhe Shen
Journal:  J Biol Chem       Date:  2020-02-18       Impact factor: 5.157

4.  Discovering sparse transcription factor codes for cell states and state transitions during development.

Authors:  Leon A Furchtgott; Samuel Melton; Vilas Menon; Sharad Ramanathan
Journal:  Elife       Date:  2017-03-15       Impact factor: 8.140

5.  Involvement of DNA Damage Response via the Ccndbp1-Atm-Chk2 Pathway in Mice with Dextran-Sodium-Sulfate-Induced Colitis.

Authors:  Ryoko Horigome; Kenya Kamimura; Yusuke Niwa; Kohei Ogawa; Ken-Ichi Mizuno; Koichi Fujisawa; Naoki Yamamoto; Taro Takami; Tomoyuki Sugano; Akira Sakamaki; Hiroteru Kamimura; Masaaki Takamura; Shuji Terai
Journal:  J Clin Med       Date:  2022-06-25       Impact factor: 4.964

6.  Prohibitin 1 modulates mitochondrial function of Stat3.

Authors:  Jie Han; Chunhua Yu; Rhonda F Souza; Arianne L Theiss
Journal:  Cell Signal       Date:  2014-06-26       Impact factor: 4.315

7.  Therapeutic Ablation of Gain-of-Function Mutant p53 in Colorectal Cancer Inhibits Stat3-Mediated Tumor Growth and Invasion.

Authors:  Ramona Schulz-Heddergott; Nadine Stark; Shelley J Edmunds; Jinyu Li; Lena-Christin Conradi; Hanibal Bohnenberger; Fatih Ceteci; Florian R Greten; Matthias Dobbelstein; Ute M Moll
Journal:  Cancer Cell       Date:  2018-08-13       Impact factor: 31.743

8.  IL-11 Attenuates Liver Ischemia/Reperfusion Injury (IRI) through STAT3 Signaling Pathway in Mice.

Authors:  Miao Zhu; Bo Lu; Qinhong Cao; Zhenfeng Wu; Zhe Xu; Weisu Li; Xuequan Yao; Fukun Liu
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

Review 9.  STAT3-Activating Cytokines: A Therapeutic Opportunity for Inflammatory Bowel Disease?

Authors:  Paul M Nguyen; Tracy L Putoczki; Matthias Ernst
Journal:  J Interferon Cytokine Res       Date:  2015-03-11       Impact factor: 2.607

10.  IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis.

Authors:  Matjaz Rokavec; Meryem Gülfem Öner; Huihui Li; Rene Jackstadt; Longchang Jiang; Dmitri Lodygin; Markus Kaller; David Horst; Paul K Ziegler; Sarah Schwitalla; Julia Slotta-Huspenina; Franz G Bader; Florian R Greten; Heiko Hermeking
Journal:  J Clin Invest       Date:  2014-03-18       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.